Boehringer has infringed 74 Humira patents, claims AbbVie

03-08-2017

Boehringer has infringed 74 Humira patents, claims AbbVie

fstop123 / iStockphoto.com

Boehringer Ingelheim has infringed 74 of AbbVie’s patents relating to arthritis medication Humira (adalimumab), AbbVie has alleged.


AbbVie, patent, patent infringement, Boehringer Ingelheim, Humira, BPCIA, biologics, arthritis

LSIPR